Implementation of Anal Cancer Screening and Treatment in Nigeria

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorUniversity of Maryland, Baltimore

About this trial

The study is a feasibility pilot trial testing 2 types of training protocols on a single physician. The first training protocol is the current standard and was developed in high-income settings. The second training protocol will be developed so tailored to the Nigerian setting. Investigators will test if the physician performs differently in their ability to conduct anal cancer screening and treatment between the 2 training protocols.

Eligibility criteria

Qualifiers

Possess a medical degree in medical sciences (MBBS or equivalent)

At least 2-5 years of experience working with clinical HIV/AIDS community

Must be registered with the medical and dental council of Nigeria

Possess a current medical practicing license

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Enhanced Training on screening and treatment of HSIL (e-STH)

Treatment groups

1 Participants
are divided into 2 treatment groups

Sponsors and collaborators

University of Maryland, Baltimore

Lead sponsor

National Cancer Institute (NCI)

Collaborator